Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jianling Xie, Halina Mikolajek, Craig R. Pigott, Kelly J. Hooper, Toby Mellows, Claire E. Moore, Hafeez Mohammed, Jörn M. Werner, Gareth J. Thomas & Christopher G. Proud. (2015) Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival. Molecular and Cellular Biology 35:10, pages 1805-1824.
Read now
Read now
Articles from other publishers (26)
Busra Turgu, Amal El‐Naggar, Melanie Kogler, Luigi Tortola, Hai‐Feng Zhang, Mariam Hassan, Michael M Lizardo, Sonia HY Kung, Wan Lam, Josef M Penninger & Poul H Sorensen. (2023)
The
HACE1 E3
ligase mediates
RAC1
‐dependent control of
mTOR
signaling complexes
. EMBO reports 24:12.
Crossref
Crossref
Erin R. Cullen, Kamran Tariq, Amy N. Shore, Bryan W. Luikart & Matthew C. Weston. (2022) mTORC2 inhibition improves morphological effects of PTEN loss, but does not correct synaptic dysfunction or prevent seizures. The Journal of Neuroscience, pages JN-RM-1354-22.
Crossref
Crossref
Polina Kosillo, Kamran M Ahmed, Erin E Aisenberg, Vasiliki Karalis, Bradley M Roberts, Stephanie J Cragg & Helen S Bateup. (2022) Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2. eLife 11.
Crossref
Crossref
Lin Fu, Li Zhang, Li Liu, Heng Yang, Peng Zhou, Fan Song, Guozhong Dong, Juncai Chen, Gaofu Wang & Xianwen Dong. (2021) Effect of Heat Stress on Bovine Mammary Cellular Metabolites and Gene Transcription Related to Amino Acid Metabolism, Amino Acid Transportation and Mammalian Target of Rapamycin (mTOR) Signaling. Animals 11:11, pages 3153.
Crossref
Crossref
Claudia Teufel, Edit Horvath, Annick Peter, Caner Ercan, Salvatore Piscuoglio, Michael N. Hall, Daniela Finke & Frank M. Lehmann. (2021) mTOR signaling mediates ILC3-driven immunopathology. Mucosal Immunology 14:6, pages 1323-1334.
Crossref
Crossref
Jianling Xie, Eric P. Kusnadi, Luc Furic & Luke A. Selth. (2021) Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer. Cancers 13:13, pages 3254.
Crossref
Crossref
Soumyaditya Ghosh, Kaitlyn N. Lewis, Richa Tulsian, Artem A. Astafev, Rochelle Buffenstein & Roman V. Kondratov. (2021) It's about time; divergent circadian clocks in livers of mice and naked mole‐rats. The FASEB Journal 35:5.
Crossref
Crossref
Alek S. Torres & Marina K. Holz. (2021) Unraveling the multifaceted nature of the nuclear function of mTOR. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1868:2, pages 118907.
Crossref
Crossref
Christopher G. Proud & Jianling Xie. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III
614
630
.
Yuan Gui & Chunsun Dai. (2020) mTOR Signaling in Kidney Diseases. Kidney360 1:11, pages 1319-1327.
Crossref
Crossref
Ninie Nadia Zulkipli, Rahimah Zakaria, Idris Long, Siti Fadilah Abdullah, Erma Fatiha Muhammad, Habibah A. Wahab & Teguh Haryo Sasongko. (2020) In Silico Analyses and Cytotoxicity Study of Asiaticoside and Asiatic Acid from Malaysian Plant as Potential mTOR Inhibitors. Molecules 25:17, pages 3991.
Crossref
Crossref
Anaelle A Dumas, Nicola Pomella, Gabriel Rosser, Loredana Guglielmi, Claire Vinel, Thomas O Millner, Jeremy Rees, Natasha Aley, Denise Sheer, Jun Wei, Anantha Marisetty, Amy B Heimberger, Robert L Bowman, Sebastian Brandner, Johanna A Joyce & Silvia Marino. (2020) Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment. The EMBO Journal 39:15.
Crossref
Crossref
Matthew P McCabe, Erin R Cullen, Caitlynn M Barrows, Amy N Shore, Katherine I Tooke, Kathryn A Laprade, James M Stafford & Matthew C Weston. (2020) Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission. eLife 9.
Crossref
Crossref
Luigi Formisano, Fabiana Napolitano, Roberta Rosa, Valentina D’Amato, Alberto Servetto, Roberta Marciano, Pietro De Placido, Cataldo Bianco & Roberto Bianco. (2020) Mechanisms of resistance to mTOR inhibitors. Critical Reviews in Oncology/Hematology 147, pages 102886.
Crossref
Crossref
Theres Schaub, Dennis Gürgen, Deborah Maus, Claudia Lange, Victor Tarabykin, Duska Dragun & Björn Hegner. (2019) mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells. Scientific Reports 9:1.
Crossref
Crossref
Zhong Xu, Meng Xu, Pin Liu, Shu Zhang, Runze Shang, Yu Qiao, Li Che, Silvia Ribback, Antonio Cigliano, Katja Evert, Rosa M. Pascale, Frank Dombrowski, Matthias Evert, Xi Chen, Diego F. Calvisi & Xin Chen. (2019) The mTORC2‐Akt1 Cascade Is Crucial for c‐Myc to Promote Hepatocarcinogenesis in Mice and Humans. Hepatology 70:5, pages 1600-1613.
Crossref
Crossref
Mahesh Ramalingam, Yu-Jin Huh & Yun-Il Lee. (2019) The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease. Frontiers in Neuroscience 13.
Crossref
Crossref
Yoshika Janapala, Thomas Preiss & Nikolay E. Shirokikh. (2019) Control of Translation at the Initiation Phase During Glucose Starvation in Yeast. International Journal of Molecular Sciences 20:16, pages 4043.
Crossref
Crossref
Sun‐Mi Yoo, Cheol‐Jung Lee, Han Chang Kang, Hye Suk Lee, Joo Young Lee, Kwang Dong Kim, Dae Joon Kim, Hyun‐Jung An & Yong‐Yeon Cho. (2019) Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells. Molecular Carcinogenesis.
Crossref
Crossref
X. Dong, Z. Zhou, L. Wang, B. Saremi, A. Helmbrecht, Z. Wang & J.J. Loor. (2018) Increasing the availability of threonine, isoleucine, valine, and leucine relative to lysine while maintaining an ideal ratio of lysine:methionine alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription. Journal of Dairy Science 101:6, pages 5502-5514.
Crossref
Crossref
Jianling Xie, Xuemin Wang & Christopher G. Proud. (2018) Who does TORC2 talk to?. Biochemical Journal 475:10, pages 1721-1738.
Crossref
Crossref
X. Dong, Z. Zhou, B. Saremi, A. Helmbrecht, Z. Wang & J.J. Loor. (2018) Varying the ratio of Lys:Met while maintaining the ratios of Thr:Phe, Lys:Thr, Lys:His, and Lys:Val alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription. Journal of Dairy Science 101:2, pages 1708-1718.
Crossref
Crossref
Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti & Michele Milella. (2018) mTOR Cross-Talk in Cancer and Potential for Combination Therapy. Cancers 10:1, pages 23.
Crossref
Crossref
Kirsten Thobe, Christine Sers & Heike Siebert. (2017) Unraveling the regulation of mTORC2 using logical modeling. Cell Communication and Signaling 15:1.
Crossref
Crossref
Aikaterini Lampada, James O'Prey, Gyorgy Szabadkai, Kevin M Ryan, Daniel Hochhauser & Paolo Salomoni. (2017) mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death & Differentiation 24:6, pages 1045-1062.
Crossref
Crossref
Jianling Xie, Xuemin Wang & Christopher G. Proud. (2016) mTOR inhibitors in cancer therapy. F1000Research 5, pages 2078.
Crossref
Crossref